Key Points
- Heartflow CFO Vikram Verghese sold 27,540 shares at an average price of $49.69, generating approximately $1.37 million; the sale was made under a pre-arranged Rule 10b5-1 trading plan and reduced his holdings by 11.07%.
- Heartflow shares opened at $48.91, down 1.6%, with a market capitalization of about $4.25 billion. The stock remains near its 12-month high of $51.78.
- The company reported quarterly revenue of $64.08 million, up 47.7% year over year, and an adjusted loss of $0.07 per share that beat analyst expectations; analysts maintain a consensus “Moderate Buy” rating with a $43.43 target price.
Heartflow, Inc. (NASDAQ:HTFL - Get Free Report) CFO Vikram Verghese sold 5,876 shares of the business's stock in a transaction on Wednesday, September 2nd. The shares were sold at an average price of $50.60, for a total transaction of $297,325.60. Following the transaction, the chief financial officer owned 248,683 shares in the company, valued at approximately $12,583,359.80. This represents a 2.31% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Vikram Verghese also recently made the following trade(s):
- On Thursday, September 3rd, Vikram Verghese sold 27,540 shares of Heartflow stock. The stock was sold at an average price of $49.69, for a total value of $1,368,462.60.
Heartflow Stock Performance
Shares of NASDAQ HTFL opened at $48.91 on Friday. The business has a 50 day simple moving average of $33.76 and a 200 day simple moving average of $29.92. Heartflow, Inc. has a 52 week low of $20.13 and a 52 week high of $51.78. The stock has a market cap of $4.25 billion and a price-to-earnings ratio of -26.73.
Heartflow (NASDAQ:HTFL - Get Free Report) last announced its quarterly earnings results on Thursday, August 13th. The company reported ($0.07) EPS for the quarter, topping the consensus estimate of ($0.22) by $0.15. Heartflow had a negative net margin of 55.82% and a negative return on equity of 23.52%. The company had revenue of $64.08 million for the quarter. The business's revenue for the quarter was up 47.7% on a year-over-year basis. On average, analysts predict that Heartflow, Inc. will post -0.75 EPS for the current year.
Wall Street Analysts Forecast Growth
HTFL has been the subject of several recent analyst reports. Benchmark reiterated a "buy" rating on shares of Heartflow in a research note on Friday, August 14th. Weiss Ratings upgraded Heartflow from a "sell (e+)" rating to a "sell (d-)" rating in a report on Friday, August 7th. Stifel Nicolaus increased their price target on Heartflow from $40.00 to $45.00 and gave the company a "buy" rating in a report on Friday, August 14th. JPMorgan Chase & Co. lifted their price target on shares of Heartflow from $35.00 to $45.00 and gave the company an "overweight" rating in a research report on Friday, August 14th. Finally, Robert W. Baird set a $45.00 target price on shares of Heartflow in a research note on Friday, August 14th. One investment analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, Heartflow has an average rating of "Moderate Buy" and an average target price of $43.43.
Get Our Latest Research Report on Heartflow
Institutional Investors Weigh In On Heartflow
A number of institutional investors have recently bought and sold shares of HTFL. Caitong International Asset Management Co. Ltd bought a new stake in Heartflow in the 4th quarter valued at $27,000. Russell Investments Group Ltd. bought a new position in shares of Heartflow during the 4th quarter worth about $45,000. Legal & General Group Plc bought a new position in shares of Heartflow during the 3rd quarter worth about $59,000. Essential Partners LLC acquired a new stake in shares of Heartflow during the 1st quarter valued at about $57,000. Finally, Strs Ohio bought a new stake in Heartflow in the fourth quarter valued at about $99,000.
Heartflow Company Profile
(
Get Free Report)
HeartFlow, Inc (NASDAQ: HTFL) is a medical technology company that develops non-invasive diagnostic solutions for coronary artery disease. The company's core offering translates coronary CT angiography (CTA) data into a patient-specific, three-dimensional physiological model of the coronary arteries. Using advanced image processing and computational modeling, HeartFlow's analysis estimates fractional flow reserve (FFR) values throughout the coronary tree to identify ischemia-producing lesions without the need for invasive pressure-wire measurements.
HeartFlow's cloud-based service integrates with clinical workflows: clinicians submit coronary CTA images and receive a detailed, color-coded 3D map and report that highlights lesion-specific FFR values and physiological impact.
See Also
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
